Robert Bigelow

1.6k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Robert Bigelow is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Robert Bigelow has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Robert Bigelow's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Glioma Diagnosis and Treatment (2 papers) and Brain Metastases and Treatment (2 papers). Robert Bigelow is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Glioma Diagnosis and Treatment (2 papers) and Brain Metastases and Treatment (2 papers). Robert Bigelow collaborates with scholars based in United States, France and United Kingdom. Robert Bigelow's co-authors include Mace L. Rothenberg, Daniel G. Haller, Ramesh K. Ramanathan, Amit M. Oza, N Le Bail, Carlos A. Garay, John L. Marshall, Jordan Berlin, Sunil Gupta and Lowell L. Hart and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Robert Bigelow

29 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial

2003 510 citations Robert Bigelow et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Bigelow United States	15	496	222	173	150	148	30	1.1k
Rita A. Blanchard United States	14	318 0.6×	171 0.8×	338 2.0×	127 0.8×	43 0.3×	27	1.3k
Carmela Romano Italy	20	449 0.9×	307 1.4×	113 0.7×	199 1.3×	647 4.4×	76	1.5k
Richard Vinisko United States	15	212 0.4×	307 1.4×	204 1.2×	77 0.5×	230 1.6×	36	1.2k
Dorothea Nagel Germany	10	315 0.6×	195 0.9×	55 0.3×	596 4.0×	231 1.6×	16	1.1k
Jin-Qiu Yuan China	19	496 1.0×	643 2.9×	53 0.3×	152 1.0×	81 0.5×	36	1.5k
Mary Petrelli United States	18	198 0.4×	185 0.8×	201 1.2×	338 2.3×	55 0.4×	30	1.0k
Murat Akyol Türkiye	19	511 1.0×	356 1.6×	375 2.2×	630 4.2×	71 0.5×	87	1.7k
Li‐Ju Chen Taiwan	18	207 0.4×	108 0.5×	54 0.3×	155 1.0×	63 0.4×	59	940
Manuel Maglione Austria	20	215 0.4×	172 0.8×	235 1.4×	545 3.6×	220 1.5×	82	1.3k
A.F. Smith United Kingdom	21	445 0.9×	155 0.7×	33 0.2×	309 2.1×	232 1.6×	81	1.7k

Countries citing papers authored by Robert Bigelow

Since Specialization

Citations

This map shows the geographic impact of Robert Bigelow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bigelow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bigelow more than expected).

Fields of papers citing papers by Robert Bigelow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bigelow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bigelow. The network helps show where Robert Bigelow may publish in the future.

Co-authorship network of co-authors of Robert Bigelow

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bigelow. A scholar is included among the top collaborators of Robert Bigelow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bigelow. Robert Bigelow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Tira J., Sarah Sammons, Young‐Hyuck Im, et al.. (2024). Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer. Clinical Cancer Research. 30(7). 1240–1247. 18 indexed citations

Chew, Derek S., Robert Bigelow, Patricia A. Cowper, et al.. (2023). Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial. Circulation. 148(14). 1087–1098. 6 indexed citations

Wise, Lauren A., Laine Thomas, Donna D. Baird, et al.. (2022). Route of myomectomy and fertility: a prospective cohort study. Fertility and Sterility. 117(5). 1083–1093. 13 indexed citations

Kelleher, Colm & Robert Bigelow. (2022). The 2021 Bigelow Institute for Consciousness Studies (BICS) Essay Contest. SHILAP Revista de lepidopterología. 36(2). 350–365. 3 indexed citations

Mentz, Robert J., Adam D. DeVore, Gudaye Tasissa, et al.. (2020). PredischaRge initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial. American Heart Journal. 223. 98–105. 19 indexed citations

Mentz, Robert J., Adam D. DeVore, Gudaye Tasissa, et al.. (2019). Abstract 252: PredischaRge Initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial. Circulation Cardiovascular Quality and Outcomes. 12(Suppl_1). 2 indexed citations

Crowley, Anna Lisa, Eric Yow, Huiman X. Barnhart, et al.. (2016). Critical Review of Current Approaches for Echocardiographic Reproducibility and Reliability Assessment in Clinical Research. Journal of the American Society of Echocardiography. 29(12). 1144–1154.e7. 27 indexed citations

Barnhart, Huiman X., Eric Yow, Anna Lisa Crowley, et al.. (2014). Choice of agreement indices for assessing and improving measurement reproducibility in a core laboratory setting. Statistical Methods in Medical Research. 25(6). 2939–2958. 52 indexed citations

Lópes, Renato D., Gail E. Hafley, Sandra Tourt-Uhlig, et al.. (2013). Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: Study design and conduct. American Heart Journal. 166(2). 208–216.e28. 18 indexed citations

10.

Mahaffey, Kenneth W., Gail E. Hafley, Sandra Tourt-Uhlig, et al.. (2013). Results of a reevaluation of cardiovascular outcomes in the RECORD trial. American Heart Journal. 166(2). 240–249.e1. 129 indexed citations

11.

Gressin, Virginie, et al.. (1993). Is arrhythmogenicity related to the speed of reperfusion during thrombolysis for myocardial infarction?. European Heart Journal. 14(4). 516–520. 6 indexed citations

12.

Gressin, Virginie, Anton P.M. Gorgels, Yves Louvard, H Lardoux, & Robert Bigelow. (1993). ST-Segment normalization time and ventricular arrhythmias as electrocardiographic markers of reperfusion during intravenous thrombolysis for acute myocardial infarction. The American Journal of Cardiology. 71(16). 1436–1439. 5 indexed citations

13.

Oelberg, David G., et al.. (1988). Intracranial Hemorrhage in Term or Near-term Newborns With Persistent Pulmonary Hypertension. Clinical Pediatrics. 27(1). 14–17. 7 indexed citations

14.

Gonik, Bernard, et al.. (1985). Influence of menstrual cycle variations on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to cells infected with herpes simplex virus.. PubMed. 30(6). 493–6. 7 indexed citations

15.

Gonik, Bernard, et al.. (1984). Influence of naproxen therapy on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus.. PubMed. 29(10). 722–6. 1 indexed citations

16.

Kohl, Steve, Robert Bigelow, & L S Loo. (1984). Ontogeny of Protection of Neonatal Mice from Lethal Herpes Simplex Virus Infection by Human Leukocytes, Antiviral Antibody, and Recombinant α-Interferon. Pediatric Research. 18(11). 1164–1167. 5 indexed citations

17.

Wohlleb, James C., Ernesto Pollitt, William H. Mueller, & Robert Bigelow. (1983). The bacon chow study: maternal supplementation and infant growth. Early Human Development. 9(1). 79–91. 17 indexed citations

18.

Hayman, L. Anne, et al.. (1983). Concentration of intrathecal 3H-labeled metrizamide in normal dog brain: age-related differences.. American Journal of Neuroradiology. 4(5). 1091–6. 2 indexed citations

19.

Bigelow, Robert, et al.. (1983). Contrast enhancing lesions in MS. Neurology. 33(9). 1250–1250. 2 indexed citations

20.

Ophir, J., Nabil Maklad, & Robert Bigelow. (1982). Ultrasonic Attenuation Measurements of in Vivo Human Muscle. Ultrasonic Imaging. 4(3). 290–295. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact